Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen

We have previously employed an intercellular spreading strategy using herpes simplex virus type 1 (HSV-1) VP22 protein to enhance DNA vaccine potency because DNA vaccines lack the intrinsic ability to amplify in cells. Recently, studies have demonstrated that the protein encoded by UL49 of Marek...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hung, Chien-Fu, He, Liangmei, Juang, Jeremy, Lin, Tzyy-Jye, Ling, Morris, Wu, T.-C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2002
Soggetti:
Vaccines and Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC135982/
https://ncbi.nlm.nih.gov/pubmed/11861834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.6.2676-2682.2002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi